Search Results For ''

  • Sparc testing confirms graphene as vital additive to prevent corrosion

    Graphene continues to emerge as one of the world’s most innovative materials of the future following test work by Sparc Technologies (ASX: SPN) confirming its significant performance as a protective layer that can prevent corrosion. The testing, which was performed with the University of Adelaide, saw graphene-based additives applied to various steel panels. Over 10

    Read More
    Public
  • AV uptake leads Audinate to push European expansion through recruiting drive

    A reliance on digital connectivity through the pandemic has seen rising adoption of audio tech from Audinate (ASX: AD8) as they see continued uptake of their transformational audio-visual solutions that are disrupting the need for traditional hardware devices. Reporting revenue of USD $11.1 million (unaudited) for the half-year ending 31 December 2020, Audinate’s Dante® media

    Read More
    Public
  • Bottoming longer-term rates, record prices, stagnant profits: Will the share market rally end in 2021?

    Predicting a crash can be very difficult. Many of the professional investors who called the last major crashes also predicted other crashes that never eventuated. What we do know for sure, is that there are times when share prices are cheap, and times when they are expensive. US Share prices have never been more expensive

    Read More
    Public
  • JAT Corp to open first China retail gateway following 12 month COVID delay

    It’s been a frustrating wait for dairy products company JAT Corp (ASX: JAT) but the China-focused exporter is set to finally open their first retail store in Shanghai having predominantly relied on distributors and online channels through the pandemic. Originally set to open in March 2020 as JAT Corp’s (previously Jatenergy) flagship retail store, the

    Read More
    Public
  • Quickfire FDA approval for Acrux’s testosterone sends share price soaring

    Aussie pharmaceuticals company Acrux (ASX: ACR) is quickly making inroads through the lucrative American healthcare system with regulatory approval granted for their generic equivalent of a common testosterone topical solution which generates more than $25 million annually. Approval was granted from the Food and Drug administration for Acrux’s gel following their submission in August 2018

    Read More
    Public
  • Shunning of public transport sends Wisr’s car loans vrooming

    Amid the many ways COVID-19 has brought about new business opportunities, financing fintech company Wisr (ASX: WZR) continues to benefit from Aussies being more financially responsible through the pandemic, reporting a 35% increase in loan originations, driven by vehicle financing. For the quarter ending 31 December 2020, Wisr continued its upward momentum to deliver its

    Read More
    Public